Tag: CRISPR therapeutics

November 24, 2019

5 Top NASDAQ Biotech and Pharma Stocks: Fulcrum Climbs 73 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
November 19, 2019

CRISPR and Vertex Release Positive Gene-editing Results

This is the first time CRISPR/Cas9 gene-editing technology has been used in human trials to treat genetic diseases.
February 25, 2019

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results

CRISPR Therapeutics (NASDAQ:CRSP) has announced financial results for its fourth quarter and full year ended December 31, 2018. As quoted...
February 21, 2019

The Rise of CRISPR Technology

CRISPR technology is a rapidly growing component of the genetics industry. Here's what investors need to know about its future...
November 13, 2018

CRISPR Trials to Watch in 2018

CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
October 11, 2018

CRISPR Therapeutics and Vertex Announce FDA Has Lifted a Clinical Hold

CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Vertex Pharmaceuticals (NASDAQ:VRTX) today announced...
September 21, 2018

CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares

CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today announced the pricing of...